Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Megan Malach"'
Publikováno v:
Pharmaceuticals, Vol 15, Iss 3, p 359 (2022)
The antineoplastic effects of cannabis have been known since 1975. Since the identification of the components of the endogenous cannabinoid system (ECS) in the 1990s, research into the potential of cannabinoids as medicine has exploded, including in
Externí odkaz:
https://doaj.org/article/cf9e063e177e46d1934fd19be1cf2e43
Autor:
Bo Wang, Dongping Li, Rocio Rodriguez-Juarez, Allison Farfus, Quinn Storozynsky, Megan Malach, Emily Carpenter, Jody Filkowski, Anne E. Lykkesfeldt, Olga Kovalchuk
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-13 (2018)
Abstract Background Breast cancer is the most common malignancy in women worldwide. Although the endocrine therapy that targets estrogen receptor α (ERα) signaling has been well established as an effective adjuvant treatment for patients with ERα-
Externí odkaz:
https://doaj.org/article/180db70a04884cc1b52d78dcc9f021ae
Autor:
Jody Filkowski, Olga Kovalchuk, Megan Malach, Dongping Li, Rocio Rodriguez-Juarez, Quinn Storozynsky, Emily Carpenter, Bo Wang
Publikováno v:
Oncogenesis, Vol 7, Iss 7, Pp 1-14 (2018)
Oncogenesis
Oncogenesis
Antiestrogen resistance is a major challenge encountered during the treatment of estrogen receptor alpha positive (ERα+) breast cancer. A better understanding of signaling pathways and downstream transcription factors and their targets may identify
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75cad7cb7045c860a912b69b9faf94b2
http://link.springer.com/article/10.1038/s41389-018-0063-5
http://link.springer.com/article/10.1038/s41389-018-0063-5
Autor:
Quinn Storozynsky, Rocio Rodriguez-Juarez, Dongping Li, Emily Carpenter, Olga Kovalchuk, Allison Farfus, Bo Wang, Anne E. Lykkesfeldt, Jody Filkowski, Megan Malach
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-13 (2018)
BMC Cancer
BMC Cancer
Background Breast cancer is the most common malignancy in women worldwide. Although the endocrine therapy that targets estrogen receptor α (ERα) signaling has been well established as an effective adjuvant treatment for patients with ERα-positive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43f6d95947ab8c6d2e8df36af5abfe3d
https://doi.org/10.1186/s12885-018-4711-0
https://doi.org/10.1186/s12885-018-4711-0